Patents by Inventor Mikkel Schouenborg Grubbe
Mikkel Schouenborg Grubbe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11369748Abstract: The present invention provides a drug injection device (100) comprising a first element (140) and a second element (103) configured to undergo unidirectional movement relative to each other corresponding to an action performed on or by the drug injection device (100), wherein the first element (140) comprises a plurality of serially disposed protrusions (143), wherein the second element (103) comprises first and second deflectable transducers (103a/153a, 103b/153b) configured for sequentially cooperating with the plurality of protrusions (143), and wherein a processor (151) is electrically connected with the first and second deflectable transducers (103a/153a, 103b/153b) to register activation signals, wherein the protrusion configuration is so disposed on the first element (140) and the first and second deflectable transducers (103a/153a, 103b/153b) are so disposed on the second element (103) that a second activation signal generated by the second deflectable transducer (103b/153b) is delayed relative to a fType: GrantFiled: December 4, 2018Date of Patent: June 28, 2022Assignee: Novo Nordisk A/SInventor: Mikkel Schouenborg Grubbe
-
Patent number: 11083853Abstract: A rotary sensor assembly, comprising a first sensor part with a plurality of position sensor segments, and a second sensor part with a grounded contact in contact with a position sensor segment. For a current incremental rotational position a contact is in contact with an un-powered current-position sensor segment, with the neighbour segments being in a powered state. When the contact is rotated to a powered next-position position sensor segment, the next-position sensor segment becomes a new current-position sensor segment. Electronic circuitry is adapted to detect that the new current-position sensor segment is grounded and that the first and second sensor parts thereby have been rotated one increment relative to each other, and subsequently change the state of the former current-position sensor segment from un-powered to powered and the state of the new current-position sensor segment from powered to un-powered.Type: GrantFiled: December 23, 2016Date of Patent: August 10, 2021Assignee: Novo Nordisk A/SInventor: Mikkel Schouenborg Grubbe
-
Publication number: 20210162136Abstract: The present invention provides a drug injection device (100) comprising a first element (140) and a second element (103) configured to undergo unidirectional movement relative to each other corresponding to an action performed on or by the drug injection device (100), wherein the first element (140) comprises a plurality of serially disposed protrusions (143), wherein the second element (103) comprises first and second deflectable transducers (103a/153a, 103b/153b) configured for sequentially cooperating with the plurality of protrusions (143), and wherein a processor (151) is electrically connected with the first and second deflectable transducers (103a/153a, 103b/153b) to register activation signals, wherein the protrusion configuration is so disposed on the first element (140) and the first and second deflectable transducers (103a/153a, 103b/153b) are so disposed on the second element (103) that a second activation signal generated by the second deflectable transducer (103b/153b) is delayed relative to a fType: ApplicationFiled: December 4, 2018Publication date: June 3, 2021Applicant: Novo Nordisk A/SInventor: Mikkel Schouenborg Grubbe
-
Publication number: 20200295768Abstract: The present invention relates to a crystal-free oscillator circuit (100) for channel-based high-frequency radio communication, the crystal-free oscillator circuit (100) comprising a crystal-free oscillator element (120) configured to provide a high-frequency reference signal (101), the high-frequency reference signal (101) having a frequency of at least about 1 GHz, and a phase-locked loop (PLL) circuit (110) having a feedback loop and comprising a PLL oscillator (120), wherein the phase-locked loop circuit (110) is configured to receive a high-frequency reference signal (101), to provide a feedback signal (102) in the feedback loop, and to provide a high-frequency output signal (103), the high-frequency output signal (103) being generated by the PLL oscillator (120?) in response to the high-frequency reference signal (101) and to the feedback signal (102) where the feedback signal (102) is dependent on an earlier instance of the output signal (103), wherein the crystal-free oscillator circuit (100) further cType: ApplicationFiled: November 30, 2018Publication date: September 17, 2020Inventors: Carsten Bleser Rasmussen, Ching-Hua Yang, Ander Fernandez Garcia, Mikkel Schouenborg Grubbe
-
Patent number: 10384010Abstract: Drug delivery device adapted to receive a drug-filled cartridge comprises a piston drive member for expelling a dose of drug from a loaded cartridge, a motor for driving the piston drive member, a rechargeable electric power source, an electrical connector allowing an external connector of a power source to be connected for recharging the power source, and a controller for controlling operation of the motor. The controller is adapted to detect a condition indicative of an external power source being connected to the electrical connector and subsequently disable the expelling assembly to thereby prevent that drug can be expelled from a loaded cartridge when an external power source has been connected to the electrical connector.Type: GrantFiled: December 16, 2014Date of Patent: August 20, 2019Assignee: Novo Nordisk A/SInventors: Mikkel Schouenborg Grubbe, Mads Moeller, Carsten Schau Andersen, Thomas Soerensen, Jesper Hoeholt, Steffen Mews, Pete Brockmeier, Bjoern Gullak Larsen
-
Publication number: 20180369494Abstract: A rotary sensor assembly, comprising a first sensor part with a plurality of position sensor segments, and a second sensor part with a grounded contact in contact with a position sensor segment. For a current incremental rotational position a contact is in contact with an un-powered current-position sensor segment, with the neighbour segments being in a powered state. When the contact is rotated to a powered next-position position sensor segment, the next-position sensor segment becomes a new current-position sensor segment. Electronic circuitry is adapted to detect that the new current-position sensor segment is grounded and that the first and second sensor parts thereby have been rotated one increment relative to each other, and subsequently change the state of the former current-position sensor segment from un-powered to powered and the state of the new current-position sensor segment from powered to un-powered.Type: ApplicationFiled: December 23, 2016Publication date: December 27, 2018Inventor: Mikkel Schouenborg Grubbe
-
Patent number: 9675761Abstract: A drug delivery system (1) comprising first (35) and second reservoir units (30) with first and second identifiers (32), and a main unit (10) adapted to receive either of the first (35) and second reservoir units (30) in a mounted position. The main unit (10) comprises drug expelling means having dose setting means (11, 1, 14, 15, 19) comprising a rotational dose setting member allowing a user to set a desired dose size for the given drug, the dose size being set in fixed increments for a given state. The drug expelling means has a first state in which an increment corresponds to a first volume of drug, and a second state in which an increment corresponds to a second volume of drug, wherein the drug expelling means is set in the first state by means of the first identifier when a first reservoir unit is mounted, and the drug expelling means is set in the second state by means of the second identifier when a second reservoir unit is mounted.Type: GrantFiled: November 19, 2013Date of Patent: June 13, 2017Assignee: Novo Nordisk A/SInventors: Jesper Hoeholt, Michael Monrad, Carsten Schau Andersen, Mikkel Schouenborg Grubbe, Bennie Peder Smiszek Pedersen
-
Publication number: 20170157340Abstract: A drug delivery device comprising drug expelling means for expelling an amount of drug, a number of user-oriented structures, and individual visual communication means arranged in the vicinity of at least two user-oriented structures. The device further comprises control means adapted to detect an error condition associated with each of the at least two structures, and actuate the visual communication means associated with a structure for which an error condition has been detected.Type: ApplicationFiled: April 29, 2015Publication date: June 8, 2017Inventors: Mads Moeller, Mikkel Schouenborg Grubbe, Michael Svendsmark Hansen
-
Publication number: 20160331901Abstract: Drug delivery device adapted to receive a drug-filled cartridge comprises a piston drive member for expelling a dose of drug from a loaded cartridge, a motor for driving the piston drive member, a rechargeable electric power source, an electrical connector allowing an external connector of a power source to be connected for recharging the power source, and a controller for controlling operation of the motor. The controller is adapted to detect a condition indicative of an external power source being connected to the electrical connector and subsequently disable the expelling assembly to thereby prevent that drug can be expelled from a loaded cartridge when an external power source has been connected to the electrical connector.Type: ApplicationFiled: December 16, 2014Publication date: November 17, 2016Inventors: Mikkel Schouenborg Grubbe, Mads Moeller, Carsten Schau Andersen, Thomas Soerensen, Jesper Hoeholt, Steffen Mews, Pete Brockmeier, Bjoern Gullak Larsen
-
Publication number: 20150297835Abstract: A drug delivery system (1) comprising first (35) and second reservoir units (30) with first and second identifiers (32), and a main unit (10) adapted to receive either of the first (35) and second reservoir units (30) in a mounted position. The main unit (10) comprises drug expelling means having dose setting means (11, 1, 14, 15, 19) comprising a rotational dose setting member allowing a user to set a desired dose size for the given drug, the dose size being set in fixed increments for a given state. The drug expelling means has a first state in which an increment corresponds to a first volume of drug, and a second state in which an increment corresponds to a second volume of drug, wherein the drug expelling means is set in the first state by means of the first identifier when a first reservoir unit is mounted, and the drug expelling means is set in the second state by means of the second identifier when a second reservoir unit is mounted.Type: ApplicationFiled: November 19, 2013Publication date: October 22, 2015Inventors: Jesper Hoeholt, Michael Monrad, Carsten Schau Andersen, Mikkel Schouenborg Grubbe, Bennie Peder Smiszek Pedersen